Overall rank by patents
#35,136
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, active 2017–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
The verdict
Emisense holds 7 US patents across 7 technology areas, rank #35,136 of 50,000 tracked assignees.
Emisense Technologies, Llc has been granted 7 US utility patents between 2017 and 2019, placing Emisense Technologies, Llc at rank #35,136 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.7 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Emisense Technologies, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Emisense sits between Elyse Enterprises Llc (7 patents, rank #35,132) and Emplase Medical Technologies, Llc (7 patents, rank #35,140) - the closest US assignees by grant volume. The composite Innovation Score of 25.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 7 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Emisense Technologies, Llc's 14.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Emisense Technologies, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ELYSE ENTERPRISES LLC
7 patents
EMBR Labs IP LLC
7 patents
EMEFCY LTD.
7 patents
EMFIT OY
7 patents
EMMECI S.P.A.
7 patents
EMONSTER INC
7 patents
EMP IP Holding Company, LLC
7 patents
EMPLASE MEDICAL TECHNOLOGIES, LLC
7 patents
EMISENSE TECHNOLOGIES, LLC
7 patents
What this shows Emisense holds 7 patents at rank #35,136, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,136 in granted patent volume.
Other assignees with the most granted patents in Emisense's primary technology class.
Emisense's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 83% higher than 17% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 42.9% |
| 2018 | 3 | 42.9% |
| 2019 | 1 | 14.3% |
Top 7 of 7 technology areas
Overall rank by patents
#35,136
Across all tracked assignees
25.4 out of 100
How to use this portfolio
Emisense's 7 grants land it in the top 83% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.